Report Categories
View AllRecent Articles
View All
EBS Emergent BioSolutions crushes EPS estimates by 183 but faces revenue headwinds with 30 annual decline shares edge higher
STWD STARWOOD slips 18 as Q4 2025 EPS comes in 2 below consensus analyst forecasts
McEwen MUX Stock Is It Reasonably Valued Q4 2025 EPS Beats Forecasts
XAIR Beyond Air matches Q1 2026 analyst EPS estimates shares fall 179 percent on muted investor sentiment